Concepedia
Statistics
Publications
11
Citations
825
H-Index
Active since
2018
Affiliations
Massachusetts General Hospital(Current)
Harvard University
Dana-Farber Cancer Institute
Memorial Sloan Kettering Cancer Center
Guardant (United States)
Marguerite Rooney is an author at Massachusetts General Hospital specializing in medicine, oncology, and pathology.
Top concepts
MedicineOncologyPathologyCancer TherapyMolecular DiagnosticsHealthGeneticsGenomicsRadiologyEngineering
Publications per year
2018–2022
MET Alterations Are a Recurring and Actionable Resistance Mechanism in ALK-Positive Lung Cancer
Ibiayi Dagogo‐Jack, Satoshi Yoda, Jochen K. Lennerz et al. · Clinical Cancer Research · 2020 · 188 citations · Full text
Treatment with Next-Generation ALK Inhibitors Fuels Plasma <i>ALK</i> Mutation Diversity
Ibiayi Dagogo‐Jack, Marguerite Rooney, Rebecca J. Nagy et al. · Clinical Cancer Research · 2019 · 149 citations · Full text
Molecular Analysis of Plasma From Patients With ROS1-Positive NSCLC
Ibiayi Dagogo‐Jack, Marguerite Rooney, Rebecca J. Nagy et al. · Journal of Thoracic Oncology · 2019 · 94 citations · Full text
Medicine, Pathology, Molecular Pathology +2
Comprehensive analysis of tumour initiation, spatial and temporal progression under multiple lines of treatment
Ignaty Leshchiner, Dimitri Livitz, Justin F. Gainor et al. · 2018 · 85 citations · Full text
Engineering, Genetics, Evolutionary Trajectories +27
Efficacy of Platinum/Pemetrexed Combination Chemotherapy in ALK-Positive NSCLC Refractory to Second-Generation ALK Inhibitors
Adam J. Schoenfeld, Viola W. Zhu, Beow Y. Yeap et al. · Journal of Thoracic Oncology · 2019 · 70 citations · Full text
Medicine, Pharmacology, Alk-positive Nsclc Refractory +7
1–5 of 11